Endotoxin adsorption therapy using polymyxin B-immobilized fiber as a treatment for septic shock-associated severe acute cholangitis

Springer Science and Business Media LLC - Tập 6 - Trang 390-394 - 2013
Yoshihiro Inoue1, Yasuhisa Fujino1, Makoto Onodera1, Satoshi Kikuchi1, Gaku Takahashi1, Masahiro Kojika1, Shigeatsu Endo1
1Department of Critical Care Medicine, Iwate Medical University, Morioka, Japan

Tóm tắt

The application of endotoxin adsorption therapy for severe acute cholangitis is controversial. We present a survival case of septic shock and multiple organ failure due to severe acute cholangitis. The patient was treated by endotoxin adsorption therapy using polymyxin B-immobilized fiber because he continued to remain in shock even after successful endoscopic nasobiliary drainage. The patient was an 84-year-old male diagnosed with acute cholangitis and acute pancreatitis who was transferred to our department because of shock and severe dyspnea. The patient had already developed acute respiratory failure, acute renal failure, and disseminated intravascular coagulation. We performed endoscopic nasobiliary drainage immediately, but the patient continued to remain in shock and plasma endotoxin level was markedly elevated at 133.6 pg/mL. Therefore, we performed direct hemoperfusion with polymyxin B-immobilized fiber. On starting the hemoperfusion, blood pressure and urine volume increased, and the plasma endotoxin level reduced considerably. On the basis of our experience in this case, we think that direct hemoperfusion with polymyxin B-immobilized fiber may be a useful modality in the management of severe acute cholangitis.

Tài liệu tham khảo

Lau JY, Chung SC, Leung JW, Ling TK, Yung MY, Li AK. Endoscopic drainage aborts endotoxaemia in acute cholangitis. Br J Surg. 1996;83(2):181–4. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–55. Yaegashi Y, Inada K, Sato N, Kojika M, Endo S. Highly sensitive endotoxin assey for the diagnosis of sepsis. Jpn J Crit Care Endotoxemia. 2003;7(1):25–8. Takada T, Kawarada Y, Nimura Y, Yoshida M, Mayumi T, Sekimoto M, et al. Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg. 2007;14(1):1–10. Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gomi H, Yoshida M, et al. TG13: updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):1–7. Charcot M. De la fievre hepatique symptomatique. Comparison avec la fievre uroseptique. Lecons sur les maladies du foie des voies biliares et des reins [Of symptomatic hepatic fever. Comparison with uroseptic fever. Lessons on diseases of the liver, biliary tract and kidneys]. Paris: Bourneville et Sevestre; 1877. pp. 176-85 Wada K, Takada T, Kawarada Y, Nimura Y, Miura F, Yoshida M, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):52–8. Miura F, Takada T, Kawarada Y, Nimura Y, Wada K, Hirota M, et al. Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):27–34. Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, et al. TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2013;20(1):24–34. Miura F, Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gouma DJ, et al. TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20(1):47–54. Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992;326(24):1582–6. Onoyama H, Tomita M, Sako T, Miki T, Obara S, Yamazaki T, et al. Multiple organ failure on acute obstructive suppurative cholangitis (in Japanese). J Abdom Emerg Med. 1993;13(5):679–84. Reynolds BM, Dargan EL. Acute obstructive cholangitis; a distinct clinical syndrome. Ann Surg. 1959;150(2):299–303. Akizuki E, Kimura Y, Nobuoka T, Nishidate T, Mizuguchi T, Tatsumi H, et al. Evaluation of the severity and prognostic factors in patients with acute cholangitis (in Japanese with English abstract). J Abdom Emerg Med. 2008;28(1):13–7. Higashiguchi T, Kawarada Y, Yokoi H, Ito A, Ido M. Clinical evaluation and treatment in elderly patients with acute obstructive suppurative cholangitis. J Hepatobiliary Pancreat Surg. 1996;3(1):23–6. Longmire WP. Suppurative cholangitis. In: Hardy JD, editor. Critical Surgical Illness. New York: Saunders; 1971. p. 397–424. O’Connor MJ, Schwartz ML, McQuarrie DG, Sumer HW. Acute bacterial cholangitis: an analysis of clinical manifestation. Arch Surg. 1982;117(4):437–41. Csendes A, Diaz JC, Burdiles P, Maluenda F, Morales E. Risk factors and classification of acute suppurative cholangitis. Br J Surg. 1992;79(7):655–8. Endo S, Inada K, Inoue Y, Kuwata Y, Suzuki M, Yamashita H, et al. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock. 1992;38(4):264–74. Kanazawa A, Kinoshita H, Hirohashi K, Kubo S, Tsukamoto T, Hamba H, et al. Concentrations of bile and serum endotoxin and serum cytokines after biliary drainage for acute cholangitis. Osaka City Med J. 1997;43(1):15–27. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Therap Apher Dial. 2006;10(1):12–8. Hirose S, Onoyama H, Kibe N, Nomura H. A case of acute cholangitis successfully treated with PMX-DHP (in Japanese with English abstract). J Jpn Biliary Assoc. 2006;20(2):219–23. Masui K, Ueda S, Aizawa S, Ueyama T, Fukushima H, Hata N, et al. A case of septic shock by acute obstructive suppurative cholangitis treated successfully with endotoxin absorption therapy (in Japanese with English abstract). J Nara Med Assoc. 2000;51(4):250–5. Jaber BL, Barrett TW, Cendoroglo Neto M, Sundaram S, King AJ, Pereira BJ. Endotoxin removal by polymyxin-B immobilized polystyrene-derivative fibers during in vitro hemoperfusion of 10 % human plasma. ASAIO J. 1998;44(1):54–61. Yamashita H, Kumagai K, Kaneko T, Oda Y, Morikage N, Tsuruta R, et al. A case of septic shock (Klebsiella pneumoniae cholecysto-cholangitis) successfully treated with combined PMX-DHP and CHDF (in Japanese with English abstract). Jpn J Crit Care Endotoxemia. 2003;7(1):60–5. Nakazawa K, Oka M, Shingaki N, Shiraki T, Ueda K, Tomeki T, et al. A case of multiple organ failure due to acute obstructive suppurative cholangitis successfully treated with combined PMX-DHP and CHDF (in Japanese with English abstract). Shokakika. 2007;44(4):430–3.